Current Valuation
N/A
As of September 18, 2025
Total Funding Raised
$38.3M
Last Round
Merger/Acquisition

Amount undisclosed

Last Funding
Sep 2025

Funding date

Capital Efficiency
N/A

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones

No funding history available

Funding data has not been imported for this company yet

Valuation Analysis

Current Valuation Metrics

iCare is currently valued at N/A as of September 18, 2025. The company has raised a total of $38.3M in funding.

Investment Perspective

iCare's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.

Track iCare Valuation Updates

Get notified when iCare raises new funding or valuation changes

What is iCare Worth in 2025?

As of 2025, iCare is valued at N/A, based on the company's Merger/Acquisition funding round in September 18, 2025. This valuation positions iCare as one of the leading private companies in the sector.

iCare Valuation History

iCare's funding history demonstrates steady growth and investor confidence.

How iCare Valuation is Determined

Private company valuations like iCare's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:

  • Revenue growth and financial performance
  • Market opportunity and total addressable market (TAM)
  • Competitive positioning and market share
  • Management team strength and execution capability
  • Technology and intellectual property
  • Industry trends and investor sentiment

iCare Valuation FAQs

Is iCare profitable?

iCare has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.

How does iCare's valuation compare to competitors?

iCare is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.

When will iCare IPO?

iCare has not announced plans for an initial public offering. Until an IPO, investors can access iCare shares through secondary market platforms.